Asthma in the Elderly: The Role of Vitamin D
Primary Purpose
Asthma in the Elderly
Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Vitamin D 2,000 I.U.
Sponsored by

About this trial
This is an interventional treatment trial for Asthma in the Elderly focused on measuring asthma, elderly, vitamin D
Eligibility Criteria
Inclusion Criteria:
- Asthma, age of 65 years old or older
Exclusion Criteria:
- Current smokers, subjects who smoked more than 10 pack/year, subjects taking digoxin, subjects with liver disease
Sites / Locations
- Rohr and Columbo Asthma, Allergy and Immunology Specialists
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Vitamin D 2,000 I.U. daily
Arm Description
Study subjects will take 2,000 I.U. vitamin D daily for three months
Outcomes
Primary Outcome Measures
Improvement in Asthma Control Test (ACT) score
Secondary Outcome Measures
Improvement in pulmonary function tests values (FEV1%, etc.)
Full Information
NCT ID
NCT01730976
First Posted
November 15, 2012
Last Updated
September 8, 2014
Sponsor
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
1. Study Identification
Unique Protocol Identification Number
NCT01730976
Brief Title
Asthma in the Elderly: The Role of Vitamin D
Official Title
Asthma in the Elderly: The Role of Vitamin D
Study Type
Interventional
2. Study Status
Record Verification Date
September 2014
Overall Recruitment Status
Completed
Study Start Date
November 2012 (undefined)
Primary Completion Date
March 2013 (Actual)
Study Completion Date
March 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
We will study whether taking vitamin D improves asthma control and spirometric values in elderly asthmatics.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma in the Elderly
Keywords
asthma, elderly, vitamin D
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Vitamin D 2,000 I.U. daily
Arm Type
Experimental
Arm Description
Study subjects will take 2,000 I.U. vitamin D daily for three months
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin D 2,000 I.U.
Other Intervention Name(s)
Vitamin Shoppe
Primary Outcome Measure Information:
Title
Improvement in Asthma Control Test (ACT) score
Time Frame
Three months
Secondary Outcome Measure Information:
Title
Improvement in pulmonary function tests values (FEV1%, etc.)
Time Frame
Three months
Other Pre-specified Outcome Measures:
Title
Serum vitamin D and calcium levels
Time Frame
Three months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Asthma, age of 65 years old or older
Exclusion Criteria:
Current smokers, subjects who smoked more than 10 pack/year, subjects taking digoxin, subjects with liver disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michele Columbo, M.D.
Organizational Affiliation
Rohr and Columbo Associates
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rohr and Columbo Asthma, Allergy and Immunology Specialists
City
Bryn Mawr
State/Province
Pennsylvania
ZIP/Postal Code
19010
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
25221606
Citation
Columbo M, Panettieri RA Jr, Rohr AS. Asthma in the elderly: a study of the role of vitamin D. Allergy Asthma Clin Immunol. 2014 Sep 5;10(1):48. doi: 10.1186/1710-1492-10-48. eCollection 2014.
Results Reference
derived
Learn more about this trial
Asthma in the Elderly: The Role of Vitamin D
We'll reach out to this number within 24 hrs